Release from the hepatocyte may involve the very low density lipoprotein secretory pathway.

High blood levels of VLDL (very low density lipoprotein) also causes more atherosclerosis.

Very low density lipoprotein Normal VLDL cholesterol level is between 5 and 40 mg/dL.

Apolipoprotein C-III is a protein component of very low density lipoprotein (VLDL).

From the liver, the fat released from chylomicron remnants can be re-exported to the blood as the triglyceride component of very low density lipoprotein (VLDL).

Total cholesterol measures the combination of LDL, HDL, and VLDL (very low density lipoprotein) in your bloodstream.

After they leave the liver, triglygerides are packaged inside a type of protein (called very low density lipoprotein) and then can be transported in the blood to where they are needed.

In some human studies, the supplement increased blood levels of C-reactive protein, oxidized blood fats and very low density lipoprotein, along with reduced levels of high density lipoproteins.

High serum concentration of low-density lipoprotein (LDL, "bad if elevated concentrations and small"), and / or very low density lipoprotein (VLDL) particles, i.e., "lipoprotein subclass analysis"

This study was specific to hepatic SOAT, which plays a major role in hepatic production and release of very low density lipoprotein (VLDL), release of cholesterol, foam cell formation, and atherogenesis.

Bassen-Kornzweig disease, also called Bassen-Kornzweig Syndrome, is a rare congenital disorder in which the body fails to produce chylomicrons, a low density lipoprotein (LDL) and very low density lipoprotein (VLDL).

It docks to the intracellular part of the Reelin very low density lipoprotein receptor (VLDLR) and apoE receptor type 2 (ApoER2) and becomes tyrosine-phosphorylated following binding of Reelin to cortical neurons.

This condition is caused by a mutation in apolipoprotein E (ApoE), that serves as a ligand for the liver receptors for chylomicrons, IDL and VLDL or Very Low Density lipoprotein receptors.

Berger et al., in a study of the cholesterol-lowering properties of amaranth grain and oil in hamsters, report that amaranth oil significantly reduced non-HDL cholesterol and raised HDL cholesterol, as well as lowering very low density lipoprotein cholesterol (VLDL cholesterol) by 21-50%.